Digital Therapeutics Market

Digital Therapeutics Market - Global Industry Assessment & Forecast

Biotechnology and Life Sciences

# Pages:

156

Base Year:

2022

Feb - 2022

Format:

Report Code:

VMR-1327

Segments Covered

By Application Diabetes, Obesity, CVD, CNS Disease, Respiratory Diseases, Smoking Cessation, Others
By End-Use Patients, Providers, Payers, Employers, Others
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Standard License

$ 4299 USD

Multi User License

$ 6599 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2022
Forecast Years:	2023 - 2030
Historical Years:	2017 - 2021
Revenue 2022:	USD 4.8 Billion
Revenue 2030:	USD 18.72 Billion
Revenue CAGR (2023 - 2030):	30.08%
Fastest Growing Region (2023 - 2030)	Asia Pacific
Largest Region (2022):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Digital Therapeutics Market - Segment Analysis
1. Overview
2. Global Digital Therapeutics Market, 2016 - 2028 (USD Million)
3. Global Digital Therapeutics Market - by Application
  1. By Diabetes
  2. By Obesity
  3. By CVD
  4. By CNS Disease
  5. By Respiratory Diseases
  6. By Smoking Cessation
  7. By Others
4. Global Digital Therapeutics Market - by End-Use
  1. By Patients
  2. By Providers
  3. By Payers
  4. By Employers
  5. By Others
5. Global Digital Therapeutics Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
6. Market comparative analysis
North America Digital Therapeutics Market - Segment Analysis
1. Overview
2. North America Digital Therapeutics Market, 2016 - 2028 (USD Million)
3. North America Digital Therapeutics Market, by Application
  1. By Diabetes
  2. By Obesity
  3. By CVD
  4. By CNS Disease
  5. By Respiratory Diseases
  6. By Smoking Cessation
  7. By Others
4. North America Digital Therapeutics Market, by End-Use
  1. By Patients
  2. By Providers
  3. By Payers
  4. By Employers
  5. By Others
5. North America Digital Therapeutics Market, by Country
  1. U.S.
    1. U.S. Digital Therapeutics Market, By Application
      1. By Diabetes
      2. By Obesity
      3. By CVD
      4. By CNS Disease
      5. By Respiratory Diseases
      6. By Smoking Cessation
      7. By Others
    2. U.S. Digital Therapeutics Market, By End-Use
      1. By Patients
      2. By Providers
      3. By Payers
      4. By Employers
      5. By Others
  2. Canada
    1. Canada Digital Therapeutics Market, By Application
      1. By Diabetes
      2. By Obesity
      3. By CVD
      4. By CNS Disease
      5. By Respiratory Diseases
      6. By Smoking Cessation
      7. By Others
    2. Canada Digital Therapeutics Market, By End-Use
      1. By Patients
      2. By Providers
      3. By Payers
      4. By Employers
      5. By Others
  3. Mexico
    1. Mexico Digital Therapeutics Market, By Application
      1. By Diabetes
      2. By Obesity
      3. By CVD
      4. By CNS Disease
      5. By Respiratory Diseases
      6. By Smoking Cessation
      7. By Others
    2. Mexico Digital Therapeutics Market, By End-Use
      1. By Patients
      2. By Providers
      3. By Payers
      4. By Employers
      5. By Others
Europe Digital Therapeutics Market - Segment Analysis
1. Overview
2. Europe Digital Therapeutics Market, 2016 - 2028 (USD Million)
3. Europe Digital Therapeutics Market, by Application
  1. By Diabetes
  2. By Obesity
  3. By CVD
  4. By CNS Disease
  5. By Respiratory Diseases
  6. By Smoking Cessation
  7. By Others
4. Europe Digital Therapeutics Market, by End-Use
  1. By Patients
  2. By Providers
  3. By Payers
  4. By Employers
  5. By Others
5. Europe Digital Therapeutics Market, by Country
  1. Germany
    1. Germany Digital Therapeutics Market, By Application
      1. By Diabetes
      2. By Obesity
      3. By CVD
      4. By CNS Disease
      5. By Respiratory Diseases
      6. By Smoking Cessation
      7. By Others
    2. Germany Digital Therapeutics Market, By End-Use
      1. By Patients
      2. By Providers
      3. By Payers
      4. By Employers
      5. By Others
  2. UK
    1. UK Market, By Application
      1. By Diabetes
      2. By Obesity
      3. By CVD
      4. By CNS Disease
      5. By Respiratory Diseases
      6. By Smoking Cessation
      7. By Others
    2. UK Market, By End-Use
      1. By Patients
      2. By Providers
      3. By Payers
      4. By Employers
      5. By Others
  3. France
    1. France Digital Therapeutics Market, By Application
      1. By Diabetes
      2. By Obesity
      3. By CVD
      4. By CNS Disease
      5. By Respiratory Diseases
      6. By Smoking Cessation
      7. By Others
    2. France Digital Therapeutics Market, By End-Use
      1. By Patients
      2. By Providers
      3. By Payers
      4. By Employers
      5. By Others
  4. Spain
    1. Spain Digital Therapeutics Market, By Application
      1. By Diabetes
      2. By Obesity
      3. By CVD
      4. By CNS Disease
      5. By Respiratory Diseases
      6. By Smoking Cessation
      7. By Others
    2. Spain Digital Therapeutics Market, By End-Use
      1. By Patients
      2. By Providers
      3. By Payers
      4. By Employers
      5. By Others
  5. Italy
    1. Italy Digital Therapeutics Market, By Application
      1. By Diabetes
      2. By Obesity
      3. By CVD
      4. By CNS Disease
      5. By Respiratory Diseases
      6. By Smoking Cessation
      7. By Others
    2. Italy Digital Therapeutics Market, By End-Use
      1. By Patients
      2. By Providers
      3. By Payers
      4. By Employers
      5. By Others
  6. BENELUX
    1. BENELUX Digital Therapeutics Market, By Application
      1. By Diabetes
      2. By Obesity
      3. By CVD
      4. By CNS Disease
      5. By Respiratory Diseases
      6. By Smoking Cessation
      7. By Others
    2. BENELUX Digital Therapeutics Market, By End-Use
      1. By Patients
      2. By Providers
      3. By Payers
      4. By Employers
      5. By Others
  7. Rest of Europe
    1. Rest Of Europe Digital Therapeutics Market, By Application
      1. By Diabetes
      2. By Obesity
      3. By CVD
      4. By CNS Disease
      5. By Respiratory Diseases
      6. By Smoking Cessation
      7. By Others
    2. Rest Of Europe Digital Therapeutics Market, By End-Use
      1. By Patients
      2. By Providers
      3. By Payers
      4. By Employers
      5. By Others
Asia Pacific Digital Therapeutics Market - Segment Analysis
1. Overview
2. Asia Pacific Digital Therapeutics Market, 2016 - 2028 (USD Million)
3. Asia Pacific Digital Therapeutics Market, by Application
  1. By Diabetes
  2. By Obesity
  3. By CVD
  4. By CNS Disease
  5. By Respiratory Diseases
  6. By Smoking Cessation
  7. By Others
4. Asia Pacific Digital Therapeutics Market, by End-Use
  1. By Patients
  2. By Providers
  3. By Payers
  4. By Employers
  5. By Others
5. Asia Pacific Digital Therapeutics Market, by Country
  1. China
    1. China Digital Therapeutics Market, By Application
      1. By Diabetes
      2. By Obesity
      3. By CVD
      4. By CNS Disease
      5. By Respiratory Diseases
      6. By Smoking Cessation
      7. By Others
    2. China Digital Therapeutics Market, By End-Use
      1. By Patients
      2. By Providers
      3. By Payers
      4. By Employers
      5. By Others
  2. Japan
    1. Japan Digital Therapeutics Market, By Application
      1. By Diabetes
      2. By Obesity
      3. By CVD
      4. By CNS Disease
      5. By Respiratory Diseases
      6. By Smoking Cessation
      7. By Others
    2. Japan Digital Therapeutics Market, By End-Use
      1. By Patients
      2. By Providers
      3. By Payers
      4. By Employers
      5. By Others
  3. India
    1. India Digital Therapeutics Market, By Application
      1. By Diabetes
      2. By Obesity
      3. By CVD
      4. By CNS Disease
      5. By Respiratory Diseases
      6. By Smoking Cessation
      7. By Others
    2. India Digital Therapeutics Market, By End-Use
      1. By Patients
      2. By Providers
      3. By Payers
      4. By Employers
      5. By Others
  4. South Korea
    1. South Korea Digital Therapeutics Market, By Application
      1. By Diabetes
      2. By Obesity
      3. By CVD
      4. By CNS Disease
      5. By Respiratory Diseases
      6. By Smoking Cessation
      7. By Others
    2. South Korea Digital Therapeutics Market, By End-Use
      1. By Patients
      2. By Providers
      3. By Payers
      4. By Employers
      5. By Others
  5. South East Asia
    1. South East Asia Digital Therapeutics Market, By Application
      1. By Diabetes
      2. By Obesity
      3. By CVD
      4. By CNS Disease
      5. By Respiratory Diseases
      6. By Smoking Cessation
      7. By Others
    2. South East Asia Digital Therapeutics Market, By End-Use
      1. By Patients
      2. By Providers
      3. By Payers
      4. By Employers
      5. By Others
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Digital Therapeutics Market, By Application
      1. By Diabetes
      2. By Obesity
      3. By CVD
      4. By CNS Disease
      5. By Respiratory Diseases
      6. By Smoking Cessation
      7. By Others
    2. Rest of Asia Pacific Digital Therapeutics Market, By End-Use
      1. By Patients
      2. By Providers
      3. By Payers
      4. By Employers
      5. By Others
Latin America Digital Therapeutics Market - Segment Analysis
1. Overview
2. Latin America Digital Therapeutics Market, 2016 - 2028 (USD Million)
3. Latin America Digital Therapeutics Market, by Application
  1. By Diabetes
  2. By Obesity
  3. By CVD
  4. By CNS Disease
  5. By Respiratory Diseases
  6. By Smoking Cessation
  7. By Others
4. Latin America Digital Therapeutics Market, by End-Use
  1. By Patients
  2. By Providers
  3. By Payers
  4. By Employers
  5. By Others
5. Latin America Digital Therapeutics Market, by Country
  1. Brazil
    1. Brazil Digital Therapeutics Market, By Application
      1. By Diabetes
      2. By Obesity
      3. By CVD
      4. By CNS Disease
      5. By Respiratory Diseases
      6. By Smoking Cessation
      7. By Others
    2. Brazil Digital Therapeutics Market, By End-Use
      1. By Patients
      2. By Providers
      3. By Payers
      4. By Employers
      5. By Others
  2. Argentina
    1. Argentina Digital Therapeutics Market, By Application
      1. By Diabetes
      2. By Obesity
      3. By CVD
      4. By CNS Disease
      5. By Respiratory Diseases
      6. By Smoking Cessation
      7. By Others
    2. Argentina Digital Therapeutics Market, By End-Use
      1. By Patients
      2. By Providers
      3. By Payers
      4. By Employers
      5. By Others
  3. Rest of Latin America
    1. Rest of Latin America Digital Therapeutics Market, By Application
      1. By Diabetes
      2. By Obesity
      3. By CVD
      4. By CNS Disease
      5. By Respiratory Diseases
      6. By Smoking Cessation
      7. By Others
    2. Rest of Latin America Digital Therapeutics Market, By End-Use
      1. By Patients
      2. By Providers
      3. By Payers
      4. By Employers
      5. By Others
Middle East & Africa Digital Therapeutics Market - Segment Analysis
1. Overview
2. Middle East & Africa Digital Therapeutics Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Digital Therapeutics Market, by Application
  1. By Diabetes
  2. By Obesity
  3. By CVD
  4. By CNS Disease
  5. By Respiratory Diseases
  6. By Smoking Cessation
  7. By Others
4. Middle East & Africa Digital Therapeutics Market, by End-Use
  1. By Patients
  2. By Providers
  3. By Payers
  4. By Employers
  5. By Others
5. Middle East & Africa Digital Therapeutics Market, by Country
  1. GCC Countries
    1. GCC Countries Digital Therapeutics Market, By Application
      1. By Diabetes
      2. By Obesity
      3. By CVD
      4. By CNS Disease
      5. By Respiratory Diseases
      6. By Smoking Cessation
      7. By Others
    2. GCC Countries Digital Therapeutics Market, By End-Use
      1. By Patients
      2. By Providers
      3. By Payers
      4. By Employers
      5. By Others
  2. South Africa
    1. South Africa Digital Therapeutics Market, By Application
      1. By Diabetes
      2. By Obesity
      3. By CVD
      4. By CNS Disease
      5. By Respiratory Diseases
      6. By Smoking Cessation
      7. By Others
    2. South Africa Digital Therapeutics Market, By End-Use
      1. By Patients
      2. By Providers
      3. By Payers
      4. By Employers
      5. By Others
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Digital Therapeutics Market, By Application
      1. By Diabetes
      2. By Obesity
      3. By CVD
      4. By CNS Disease
      5. By Respiratory Diseases
      6. By Smoking Cessation
      7. By Others
    2. Rest of Middle East & Africa Digital Therapeutics Market, By End-Use
      1. By Patients
      2. By Providers
      3. By Payers
      4. By Employers
      5. By Others
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. Omada Health Inc. (US)
2. WellDoc Inc. (US)
3. 2Morrow Inc (US).
4. Livongo Health (US)
5. Propeller Health (US)
6. Pear Therapeutics (US)
7. Canary Health Inc. (US)
8. Noom Health Inc. (US)
9. Mango Health Inc. (US)
10. Akili Interactive Labs (South Africa)
11. Better Therapeutics (US)
12. Happify Health (US)
13. Kaia Health (US)
14. Medtronic Plc. (Ireland)
15. Teladoc Health Inc (US)
16. and Fitbit Health Solutions (US).
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

Vantage Market Research | 24-Feb-2022

Digital Therapeutics Market Anticipated to Reach USD 14.52 Billion by 2028

FAQ

Frequently Asked Question

What is the global demand for Digital Therapeutics in terms of revenue?

The global Digital Therapeutics valued at USD 4.8 Billion in 2022 and is expected to reach USD 18.72 Billion in 2030 growing at a CAGR of 30.08%.

Which are the prominent players in the market?

The prominent players in the market are Omada Health Inc. (US), WellDoc Inc. (US), 2Morrow Inc (US)., Livongo Health (US), Propeller Health (US), Pear Therapeutics (US), Canary Health Inc. (US), Noom Health Inc. (US), Mango Health Inc. (US), Akili Interactive Labs (South Africa), Better Therapeutics (US), Happify Health (US), Kaia Health (US), Medtronic Plc. (Ireland), Teladoc Health Inc (US), and Fitbit Health Solutions (US)..

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 30.08% between 2023 and 2030.

What are the driving factors fueling the growth of the market.

The driving factors of the Digital Therapeutics include
- Increased Adoption of EHR Solutions

Which region accounted for the largest share in the market?

North America was the leading regional segment of the Digital Therapeutics in 2022.

Digital Therapeutics Market

Digital Therapeutics Market - Global Industry Assessment & Forecast

Biotechnology and Life Sciences

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Digital Therapeutics in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Vantage Market Research

Products & Services

Media

Contact Us

Digital Therapeutics Market

Digital Therapeutics Market - Global Industry Assessment & Forecast

Biotechnology and Life Sciences

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Digital Therapeutics in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Digital Therapeutics Market

Vantage Point Interactive Dashboard